Philip L. De Jager, MD, PHD

Board Certifications: 
Neurology
Accepting New Patients
Virtual Visits/Telehealth
Profile Headshot

Overview

Dr. Philip L. De Jager is professor of neurology. After graduating from Yale University with a degree in Molecular Biophysics & Biochemistry, Dr. De Jager received a PhD in Neurogenetics from Rockefeller University and an MD from Cornell University Medical College, before completing his MMSc in Clinical Investigation at Harvard Medical School (HMS) and MIT. He served as a neurology resident in the Partners Neurology Residency Program at the Massachusetts General Hospital and Brigham and Women’s Hospital. He then joined the faculty at HMS, rising to the rank of associate professor before joining CUIMC.

The goal of Dr. De Jager's work as a clinician-scientist is to apply modern methods of neuro-immunology, statistical genetics, and systems biology to the understanding of common neurodegenerative diseases. At CUIMC, Dr. De Jager serves as chief of the Department of Neurology's Division of Neuroimmunology, which focuses on characterizing and targeting the neuro-immunologic component of neurodegenerative disease. Dr. De Jager will also serve as director of a new Center for Translational & Computational Neuro-Immunology, and will also direct the Columbia University Multiple Sclerosis Center.

Academic Appointments

  • Weil-Granat Professor of Neurology (in the Taub Institute for Research on Alzheimer's Disease and the aging Brain)

Administrative Titles

  • Director, Center for Translational and Computational Neuroimmunology
  • Director, Multiple Sclerosis Center
  • Deputy Director, Taub Institute for Research on Alzheimer's Disease and the Aging Brain

Hospital Affiliations

  • NewYork-Presbyterian / Columbia University Irving Medical Center

Gender

  • Male

Schedule an Appointment

Virtual Visits/Telehealth

Virtual Visits allow you to connect with your provider from the comfort, convenience, and safety of your own home.

Schedule Virtual Visit

Phone Appointments

New and Existing Patients:

Connect Patient Portal

For existing patients, login to make an appointment, view documentation or contact your care provider.

Connect Sign In

Location(s)

710 West 168th Street
New York, NY 10032
Primary

Insurance Accepted

Aetna

  • Aetna Signature Administrators
  • EPO
  • HMO
  • Medicare Managed Care
  • NYP Employee Plan
  • NY Signature
  • POS
  • PPO
  • Student Health

AgeWell

  • Medicare Managed Care
  • Special Needs

Capital District Physician Health Plan

  • Capital District Physician Health Plan

Cigna

  • EPO
  • Great West (National)
  • HMO
  • POS
  • PPO

Emblem/GHI

  • Medicare Managed Care
  • PPO

Empire Blue Cross/Blue Shield

  • EPO
  • Medicare Managed Care
  • PPO

Health Insurance Plan of NY (HIP)

  • ConnectiCare
  • EPO
  • Essential Plan
  • HMO
  • Medicaid Managed Care
  • Medicare Managed Care
  • POS
  • PPO
  • Select Care (Exchange)
  • Vytra

Local 1199

  • Local 1199

MagnaCare (National)

  • MagnaCare

Medicare

  • Traditional Medicare

Multiplan

  • Multiplan

MVP Health Care

  • Child/Family Health Plus
  • Essential Plan
  • HMO
  • Medicaid Managed Care

Oxford Health Plans

  • Freedom
  • Liberty

United Health Care

  • Columbia Employee POS
  • Compass (Exchange)
  • HMO
  • Medicaid (Community Plan)
  • Medicare Managed Care
  • POS
  • PPO

*Please contact the provider’s office directly to verify that your particular insurance is accepted.

Credentials & Experience

Education & Training

  • MD, Cornell University Medical College
  • Internship: Beth Israel Deaconess Medical Center
  • Residency: Brigham & Women's Hospital/Massachusetts General Hospital
  • Fellowship: Brigham & Women's Hospital

Board Certifications

  • Neurology

Research

The goal of Dr. De Jager's work as a clinician-scientist is to apply modern methods of neuro-immunology, statistical genetics, and systems biology to the understanding of common neurodegenerative diseases. At CUIMC, Dr. De Jager serves as chief of the Department of Neurology's Division of Neuroimmunology, which focuses on characterizing and targeting the neuro-immunologic component of neurodegenerative disease. Dr. De Jager will also serve as director of a new Center for Translational & Computational Neuro-Immunology, and will also direct the Columbia University Multiple Sclerosis Center.